These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34051134)

  • 1. Low FODMAPs diet or usual dietary advice for the treatment of refractory gastroesophageal reflux disease: An open-labeled randomized trial.
    Rivière P; Vauquelin B; Rolland E; Melchior C; Roman S; Bruley des Varannes S; Mion F; Gourcerol G; Sacher-Huvelin S; Zerbib F
    Neurogastroenterol Motil; 2021 Sep; 33(9):e14181. PubMed ID: 34051134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.
    Takeuchi T; Hongo H; Kimura T; Kojima Y; Harada S; Ota K; Takeuchi N; Noguchi T; Inoue T; Murano M; Higuchi K
    J Gastroenterol; 2019 Nov; 54(11):972-983. PubMed ID: 31037449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial.
    Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Simrén M
    Gastroenterology; 2015 Nov; 149(6):1399-1407.e2. PubMed ID: 26255043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diaphragmatic Breathing Reduces Belching and Proton Pump Inhibitor Refractory Gastroesophageal Reflux Symptoms.
    Ong AM; Chua LT; Khor CJ; Asokkumar R; S/O Namasivayam V; Wang YT
    Clin Gastroenterol Hepatol; 2018 Mar; 16(3):407-416.e2. PubMed ID: 29104130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.
    Zahedi MJ; Behrouz V; Azimi M
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1192-1199. PubMed ID: 29159993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary carbohydrate intake, insulin resistance and gastro-oesophageal reflux disease: a pilot study in European- and African-American obese women.
    Pointer SD; Rickstrew J; Slaughter JC; Vaezi MF; Silver HJ
    Aliment Pharmacol Ther; 2016 Nov; 44(9):976-988. PubMed ID: 27582035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fiber-enriched diet helps to control symptoms and improves esophageal motility in patients with non-erosive gastroesophageal reflux disease.
    Morozov S; Isakov V; Konovalova M
    World J Gastroenterol; 2018 Jun; 24(21):2291-2299. PubMed ID: 29881238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of wu chu yu tang on gastroesophageal reflux disease: Randomized, double-blind, placebo-controlled trial.
    Shih YS; Tsai CH; Li TC; Yu CJ; Chou JW; Feng CL; Wang KT; Lai HC; Hsieh CL
    Phytomedicine; 2019 Mar; 56():118-125. PubMed ID: 30668332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor.
    Takeuchi T; Takahashi Y; Kawaguchi S; Ota K; Harada S; Kojima Y; Sakamoto H; Kuramoto T; Kojima K; Sanomura M; Hoshimoto M; Higashino T; Itabashi T; Takada K; Sakaguchi M; Tominaga K; Kusano M; Higuchi K
    J Gastroenterol Hepatol; 2018 Mar; 33(3):623-630. PubMed ID: 28865098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication.
    Frazzoni M; Piccoli M; Conigliaro R; Manta R; Frazzoni L; Melotti G
    Surg Endosc; 2013 Aug; 27(8):2940-6. PubMed ID: 23436097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet.
    Staudacher HM; Ralph FSE; Irving PM; Whelan K; Lomer MCE
    J Acad Nutr Diet; 2020 Apr; 120(4):535-547. PubMed ID: 31029650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
    Cox SR; Lindsay JO; Fromentin S; Stagg AJ; McCarthy NE; Galleron N; Ibraim SB; Roume H; Levenez F; Pons N; Maziers N; Lomer MC; Ehrlich SD; Irving PM; Whelan K
    Gastroenterology; 2020 Jan; 158(1):176-188.e7. PubMed ID: 31586453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
    Okuyama M; Nakahara K; Iwakura N; Hasegawa T; Oyama M; Inoue A; Ishizu H; Satoh H; Fujiwara Y
    Digestion; 2017; 95(4):281-287. PubMed ID: 28501868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
    Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
    Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A very low-carbohydrate diet improves gastroesophageal reflux and its symptoms.
    Austin GL; Thiny MT; Westman EC; Yancy WS; Shaheen NJ
    Dig Dis Sci; 2006 Aug; 51(8):1307-12. PubMed ID: 16871438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
    Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
    Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders.
    Abdallah J; George N; Yamasaki T; Ganocy S; Fass R
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1073-1080.e1. PubMed ID: 29913281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ninety-Six Hour Wireless Esophageal pH Study in Patients with GERD Shows that Restrictive Diet Reduces Esophageal Acid Exposure.
    Triadafilopoulos G; Korzilius JW; Zikos T; Sonu I; Fernandez-Becker NQ; Nguyen L; Clarke JO
    Dig Dis Sci; 2020 Aug; 65(8):2331-2344. PubMed ID: 31734874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.